Rosetta Genomics Receives Notice of Allowance for Key U.S. Patent for the Rosetta Lung Cancer Test
Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company has received a notice of allowance from the U.S. Patent and Trademark Office for Patent Application No.